Our in vitro data and in silico predictions led us to speculate that miR-155 and FOXP3 may down regulate endogenous ZEB2 in normal breast epithelia as part of epithelial homeostasis, and this is defective in breast cancer. The gene discussed is FOXP3; the disease is breast carcinoma.